Chancery Sets Short Sale Fuse For Troubled Drug Company
The Delaware Chancery Court agreed Monday to schedule a quick $14 million asset sale hearing for a drug development company ordered into liquidation last year amid a battle between its owner-managers,...To view the full article, register now.
Already a subscriber? Click here to view full article